Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Hypertension. 2011 Sep 19;58(5):784–790. doi: 10.1161/HYPERTENSIONAHA.111.175315

Table 4.

Lipid and glucose outcomes as a function of fatty kidney status.* Increments in each outcome associated with the presence of fatty kidney (standard errors shown in parentheses) is presented for continuous outcomes. Odds ratios (95% confidence interval) comparing those with fatty kidney to those without fatty kidney are presented for dichotomous outcomes.

Model outcomes of interest Age and sex Multivariable Multivariable + BMI Multivariable + VAT
Continuous outcomes
HDL-cholesterol (mg/dL) −4.16 (0.67)
p<0.0001
−4.14 (0.66)
p<0.0001
−1.10 (0.67)
p=0.10
1.07 (0.68)
p=0.12
Triglycerides (mg/dL), log transformed 0.20 (0.02)
p<0.0001
0.20 (0.02)
p<0.0001
0.10 (0.02)
p<0.0001
0.01 (0.02)
p=0.71
Fasting blood glucose (mg/dL) 5.66 (0.90)
p<0.0001
1.99 (0.92)
p=0.03
−0.07 (0.96)
p=0.94
Dichotomous outcomes
Low HDL-Cholesterol 1.39 (1.15 – 1.69)
p=0.0009
1.41 (1.15 – 1.72)
p=0.0008
0.99 (0.80 – 1.23)
p=0.93
0.74 (0.59 – 0.93)
p=0.009
High Triglycerides 1.89 (1.58 – 2.26)
p<0.0001
1.88 (1.58 – 2.25)
p<0.0001
1·38 – (1.14 1.66)
p=0.001
1.04 (0.85 – 1.28)
p=0.69
Diabetes 2.26 (1.66 – 3.09)
p<0.0001
1.42 (1.02 – 1.97)
p=0.04
1.09 (0.77 – 1.55)
p=0.62

Abbreviations: BMI=body mass index; HDL=high density lipoprotein; VAT=abdominal visceral adipose tissue volume.

*

Sex-specific cut points for fatty kidney: ≥ 0.71 cm2 in men; ≥ 0.445 cm2 in women.

Multivariable models are adjusted for age and sex as well as covariates as listed below:

HDL Cholesterol, log(Triglycerides), low HDL cholesterol: Current smoking status, high alcohol intake, current use of lipid lowering medication

High Triglycerides: Current smoking status

Models of fasting blood glucose and diabetes were not adjusted beyond age and sex before further adjustment for BMI or VAT